Does this have anything to do with us?
No.
A simple internet search would show that, or reading the article where the products maker, Gilead Sciences is mentioned;
"Remdesivir has been at the centre of controversy in the US, where maker of the drug Gilead Sciences"
You leave yourself open to deception if you cannot DYOR.
In the article you linked to the final paragraph is the most important for your investment in Mesoblast. The product remestemcel-L is aimed at those in danger of dying. Remdesivir on the other hand;
"had not improved survival according to preliminary results after two weeks of followup"
That is being prescribed Remdesivir does not seem to reduce your chances of dying from COVID-19 at the 2 week mark after dosage, but it does reduce hospital stays meaning those who are going to get better will get better around 4 days sooner on average, again from information in the final paragraph.
Cell Therapy News/Articles, page-4147
-
- There are more pages in this discussion • 13,677 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |